Validity and Reliability of the Sitting Assessment Scale in Cerebral Palsy

The Sitting Assessment Scale is a valid and reliable scale that evaluates sitting balance in Cerebral Palsy (CP). The validity and reliability study of the scale has been done, but it has not been adapted to Turkish language. The aim of this study is to adapt the Sitting Evaluation Scale, which evaluates sitting balance in Cerebral Palsy, into Turkish and to examine the validity and reliability of the Turkish version of the scale.

Study Overview

• Status: Completed
• Conditions: Cerebral Palsy

Detailed Description

Cerebral Palsy will be participate the study between the ages of 2 and 18 years. Children's classified with GMFCS and MACS.

Evaluation will be applied to the volunteer participants after the translation steps of the Sitting Evaluation Assessment are completed. The validity of the scale will be examined in terms of construct validity and content validity. All evaluations will be performed in the clinic with the specialist physiotherapist.

• Study Type: Observational
• Enrollment (Actual): 34

Contacts and Locations

• Study Contact: Name: Demet GÖZAÇAN KARABULUT, PhD; Phone Number: 2417 +90342 909 75 00; Email: dg.karabulut@gmail.com

Study Locations

• Turkey
  • Gaziantep, Turkey, 27010
    • Gaziantep

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 2 years to 18 years (Child, Adult)
• Accepts Healthy Volunteers: No

• Sampling Method: Probability Sample

Study Population

Cerebral Palsy will be participate the study between the ages of 2 and 18 years.

Description

Inclusion Criteria:

• Diagnosis of Cerebral Palsy voluntary participation,
• Age between 2-18 years

Exclusion Criteria:

• Not voluntary to participate in the research,
• Botox in the last 6 months,
• Hip or spine surgeries in the last 6 months

Study Plan

How is the study designed?

Design Details

• Observational Models: Other
• Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Gross Motor Function Classification System (GMFCS)	Assessing functional level and motor functions of children with CP.	At Baseline
Manuel ability classification system (MACS)	This is a classification system based on the grasping and releasing objects in daily life, and how they use their hands while holding objects. It is classify the hand skills of children with CP between the ages of 4-18.Children with CP are classified in five levels with MACS. The higher level indicates worse hand function.	At Baseline
Gross Motor Function Measure-88	It is used to show gross motor functions and changes in these functions. It consists of five main sections. Each section can be used by calculating separately within itself. The total score ranges from 0 to 100, with a high score indicating better function.	At Baseline
Trunk Control Measurement Scale	This scale consists of two main parts as dynamic and static sitting balance. The scale consists of 15 questions. The scoring of the items is 0, 1, 2 or 3. The total score ranges from 0 to 58, with a high score indicating better trunk control.	At Baseline
Sitting Assessment Scale	The Sitting Assessment Scale is a standard observation tool designed for the assessment of sitting in children with CP. The scale consists of five items evaluating head, trunk and foot control and arm and hand functions.The lowest score that can be obtained from the scale is 5 and the highest score is 20. It can be stated that higher scores better functions.	At Baseline and 2 weeks after the baseline

Collaborators and Investigators

• Sponsor: Gaziantep Islam Science and Technology University
• Investigators: Study Director: Demet Gözaçan Karabulut, Gaziantep Islam Science and Technology University

Study record dates

Study Major Dates

• Study Start (Actual): November 15, 2022
• Primary Completion (Actual): September 1, 2023
• Study Completion (Actual): September 5, 2023

Study Registration Dates

• First Submitted: November 4, 2022
• First Submitted That Met QC Criteria: November 16, 2022
• First Posted (Actual): November 17, 2022

Study Record Updates

• Last Update Posted (Actual): February 9, 2024
• Last Update Submitted That Met QC Criteria: February 8, 2024
• Last Verified: February 1, 2024

More Information

Terms related to this study

• Keywords: Cerebral Palsy; Validity
• Additional Relevant MeSH Terms: Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Neurologic Manifestations; Brain Damage, Chronic; Cerebral Palsy; Paralysis
• Other Study ID Numbers: GIBTU-FTR-DGK-2

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No